BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6971012)

  • 1. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST
    Vopr Onkol; 1984; 30(10):19-25. PubMed ID: 6093380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro immune response of patient lymphocytes to live autologous tumor cells].
    Grigor'eva MP; Kosmiadi GA; Govallo VI
    Vopr Onkol; 1980; 26(9):8-11. PubMed ID: 7423909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modifications of B lymphocyte membrane markers in patients with osteosarcoma].
    Torelli L; Marinoni I
    Boll Ist Sieroter Milan; 1976; 55(6):553-9. PubMed ID: 798595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
    Weibo P; Zhaoming Y
    Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decreased count of small lymphocytes in the blood of patients with malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Efimtseva NN; Baranovskaia VT
    Vopr Onkol; 1987; 33(9):15-21. PubMed ID: 3499033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE
    Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human peripheral blood lymphocyte cells on the basis of surface properties.
    Negro Alvarez JM
    Allergol Immunopathol (Madr); 1980; 8(6):679-84. PubMed ID: 7010971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on various parameters of the T-dependent lymphocyte system in the course of osteosarcoma].
    Marinoni I; Torelli L
    Boll Ist Sieroter Milan; 1976; 55(6):548-52. PubMed ID: 1088075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats.
    Chauvin C; Philippeau JM; Hémont C; Hubert FX; Wittrant Y; Lamoureux F; Trinité B; Heymann D; Rédini F; Josien R
    Cancer Res; 2008 Nov; 68(22):9433-40. PubMed ID: 19010918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of selected parameters of cellular immunity in children with osteosarcoma at diagnosis].
    Markiewicz K; Zeman K; Kozar A; Gołębiowska-Wawrzyniak M; Woźniak W
    Med Wieku Rozwoj; 2012; 16(3):212-21. PubMed ID: 23378399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected immunologic indicators in malignant bone tumors].
    Keleová A; Huraj E; Jahnová E; Janota S; Nyulassy S
    Acta Chir Orthop Traumatol Cech; 1990 Feb; 57(1):77-88. PubMed ID: 2336911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.
    Babusíková O; L' Novotná ; Korec S; Schneková K; Turková D; Havránková M; Plentová K
    Neoplasma; 1975; 22(4):413-21. PubMed ID: 1081657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in human osteosarcoma.
    Tsang KY; Singh I; Blakemore WS
    J Natl Cancer Inst; 1979 Apr; 62(4):743-8. PubMed ID: 285287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of the potentiating and blocking effects of the sera from tumor patients in the leukocyte migration inhibition reaction model].
    Grigor'eva MP
    Vopr Onkol; 1979; 25(1):31-8. PubMed ID: 85367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of T and B lymphocytes on the phagocytic activity of polymorphonuclear neutrophils in human peripheral blood].
    Snastina TI; Belotskiĭ SM
    Biull Eksp Biol Med; 1982 Nov; 94(11):80-2. PubMed ID: 6983898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.